Antigen Presentation to Self-reactive T Cells in Human Autoimmune Diseases
Antigen Presentation to Self-reactive T Cells in Human Autoimmune Diseases
批准号:
7432999
负责人:
Kai W Wucherpfennig
金额:
$91.46万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-09-15 至 2013-08-31
关键词:
AffectAffinityAntigen PresentationAntigen TargetingAntigen-Presenting CellsAntigensAutoantigensAutoimmune DiseasesAutoimmune ProcessAutoimmunityBindingBinding SitesBiochemicalCD4 Positive T LymphocytesCellsChimeric ProteinsChromosome PairingCollaborationsComplexDataDepthDevelopmentDiseaseDoseElementsEpithelial CellsEventExperimental Autoimmune EncephalomyelitisFundingGoalsHLA-DR2 AntigenHumanHydrogen BondingImageImmunosuppressionIn VitroIncidenceInfluenza HemagglutininInvestigationKineticsLeadLigandsMHC binding peptideMass Spectrum AnalysisMembrane ProteinsModelingMultivesicular BodyMusMyelinN-terminalNeuraxisNumbersPathogenicityPathway interactionsPatientsPeptide antibodiesPeptide/MHC ComplexPeptidesPeripheralPersonal SatisfactionPopulationProliferatingPropertyProtein DephosphorylationProteinsRelapseRoleSLC26A3 geneSignal PathwaySignal TransductionSignaling MoleculeSignaling ProteinSiteStromal CellsStructureSubfamily lentivirinaeSurfaceSynapsesT-Cell ActivationT-LymphocyteT-Lymphocyte SubsetsTCR ActivationTechniquesTherapeutic immunosuppressionThymus GlandTissuesTransgenic MiceTransgenic OrganismsTyrosineViralWorkantimicrobialbasedensityimmunological synapsein vivolymph nodesmouse modelnovelprogramsprotein degradationrelease of sequestered calcium ion into cytoplasmresearch studyresponsesynaptogenesistargeted deliverytranscription factorubiquitin ligase
中文摘要
该项目的目标是确定抗原呈递和T细胞识别机制
负责MS中髓鞘特异性CD 4 T细胞的激活。在此资助期间,Pi的实验室
确定了第一个人类自身免疫性TCR的晶体结构,并鉴定了一种不寻常的TCR结合,
topology.生物化学研究表明,这种TCR与其自身肽/MHC的低亲和力相互作用
复合物,与结构中观察到的次优结合模式一致。这种次优的绑定
模式可能有助于逃避胸腺和外周的耐受诱导,
抗原呈递细胞表达有限量的自身抗原。表达这种TCR的转基因小鼠
而人MHC限制性元件仍然以高水平发展自发性自身免疫性,
发病率,表明这些T细胞具有识别/信号传导机制,至少部分
补偿改变的TCR与自身肽/MHC的相互作用。影像学研究显示
由两种不同的髓鞘特异性神经元形成的免疫突触组织的实质性差异
人T细胞克隆与两种抗病毒T细胞克隆的比较。
在下一个融资期间,我们将确定更改后的TCR确认属性如何影响
免疫突触的形成和由此产生的信号事件。在目标1中,我们将定义
免疫突触形成的机制通过检查突触形成的动力学,
关键信号分子的募集,信号传导的持续时间以及终止的机制
通过TCR内化的信号传导。我们的假设是,次优TCR结合特性延迟TCR
TCR被转运到突触中心,在那里TCR被内化,从而延长了最初较弱的免疫反应的持续时间。
激活信号在目标2中,我们将研究这些变化如何定量地改变
自身反应性T细胞与抗病毒T细胞中的特定信号传导途径,目的是识别信号传导
这些分子对于自身反应性T细胞的活化至关重要,但对于抗病毒T细胞却至关重要。在
目的3,我们将研究是否仍然可以通过靶向递送诱导对这样的T细胞的耐受性
通过抗体-肽融合蛋白将自身肽的抗体-肽融合到淋巴结基质细胞中,
外周耐受性
英文摘要
The goal of the project is to define the antigen presentation and T cell recognition mechanisms
responsible for the activation of myelin-specific CD4 T cells in MS. During this funding period, the Pi's lab
determined the crystal structure of the first human autoimmune TCR and identified an unusual TCR binding
topology. Biochemical studies demonstrated a low affinity interaction of this TCR with its self-peptide/MHC
complex, consistent with the suboptimal binding mode observed in the structure. Such a suboptimal binding
mode may facilitate escape from tolerance induction in the thymus and periphery because the relevant
antigen presenting cells express limiting quantities of self-antigen. Transgenic mice that express this TCR
and the human MHC restriction element nevertheless develop spontaneous autoimmunity at a high
incidence, indicating that these T cells have recognition/signaling mechanisms that at least partially
compensate for the altered TCR interaction with self-peptide/MHC. Imaging studies demonstrated
substantial differences in the organization of immunological synapses formed by two different myelin-specific
human T cell clones compared to two anti-viral T cell clones.
During the next funding period, we will determine how the altered TCR recognition properties affect the
formation of immunological synapses and resulting signaling events. In Aim 1, we will define the
mechanisms of immunological synapse formation by examining the kinetics of synapse formation, the
recruitment of key signaling molecules, the duration of signaling as well as the mechanisms that terminate
signaling by TCR internalization. Our hypothesis is that the suboptimal TCR binding properties delay TCR
transport to the synapse center where TCR is internalized, thus extending the duration of the initially weaker
activation signal. In Aim 2, we will examine how these changes quantitatively modify the contribution of
particular signaling pathways in self-reactive versus anti-viral T cells, with the goal of identifying signaling
molecules that are critical for the activation of self-reactive T cells but dispensable for anti-viral T cells. In
Aim 3, we will examine whether tolerance can nevertheless be induced for such T cells by targeted delivery
of the self-peptide via an antibody-peptide fusion protein to lymph node stromal cells specialized in
peripheral tolerance.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Therapeutic Targeting of Immune Evasion from the MICA - NKG2D Pathway
-
批准号:10380449
-
项目类别:
-
资助金额:$12.57万
-
财政年份:2021
-
负责人:Kai W Wucherpfennig
-
依托单位:
Core 1: Tumor Processing and Single Cell RNA sequencing Core
-
批准号:10210225
-
项目类别:
-
资助金额:$35.69万
-
财政年份:2020
-
负责人:Kai W Wucherpfennig
-
依托单位:
Targeting of a Major Immune Evasion Pathway in Triple-negative Breast Cancer
-
批准号:10029035
-
项目类别:
-
资助金额:$48.54万
-
财政年份:2020
-
负责人:Kai W Wucherpfennig
-
依托单位:
Proj. 3: Immunosuppressive circuits in T cells and other immune cells in GBM patients enrolled in clinical trials
-
批准号:10210221
-
项目类别:
-
资助金额:$35.92万
-
财政年份:2020
-
负责人:Kai W Wucherpfennig
-
依托单位:
Targeting of a Major Immune Evasion Pathway in Triple-negative Breast Cancer
-
批准号:10224146
-
项目类别:
-
资助金额:$48.54万
-
财政年份:2020
-
负责人:Kai W Wucherpfennig
-
依托单位:
Targeting of a Major Immune Evasion Pathway in Triple-negative Breast Cancer
-
批准号:10400167
-
项目类别:
-
资助金额:$47.57万
-
财政年份:2020
-
负责人:Kai W Wucherpfennig
-
依托单位:
Proj. 3: Immunosuppressive circuits in T cells and other immune cells in GBM patients enrolled in clinical trials
-
批准号:10477984
-
项目类别:
-
资助金额:$35.2万
-
财政年份:2020
-
负责人:Kai W Wucherpfennig
-
依托单位:
Targeting of a Major Immune Evasion Pathway in Triple-negative Breast Cancer
-
批准号:10668947
-
项目类别:
-
资助金额:$47.57万
-
财政年份:2020
-
负责人:Kai W Wucherpfennig
-
依托单位:
Proj. 3: Immunosuppressive circuits in T cells and other immune cells in GBM patients enrolled in clinical trials
-
批准号:10684029
-
项目类别:
-
资助金额:$35.2万
-
财政年份:2020
-
负责人:Kai W Wucherpfennig
-
依托单位:
Core 1: Tumor Processing and Single Cell RNA sequencing Core
-
批准号:10684050
-
项目类别:
-
资助金额:$34.98万
-
财政年份:2020
-
负责人:Kai W Wucherpfennig
-
依托单位:
Core 1: Tumor Processing and Single Cell RNA sequencing Core
-
批准号:10477994
-
项目类别:
-
资助金额:$34.98万
-
财政年份:2020
-
负责人:Kai W Wucherpfennig
-
依托单位:
Therapeutic Targeting of Immune Evasion from the MICA - NKG2D Pathway
-
批准号:10524130
-
项目类别:
-
资助金额:$18.88万
-
财政年份:2019
-
负责人:Kai W Wucherpfennig
-
依托单位:
Therapeutic Targeting of Immune Evasion from the MICA - NKG2D Pathway
-
批准号:10359199
-
项目类别:
-
资助金额:$51.04万
-
财政年份:2019
-
负责人:Kai W Wucherpfennig
-
依托单位:
Therapeutic Targeting of Immune Evasion from the MICA - NKG2D Pathway
-
批准号:10596611
-
项目类别:
-
资助金额:$51.04万
-
财政年份:2019
-
负责人:Kai W Wucherpfennig
-
依托单位:
Cancer Immunology Training Grant
-
批准号:9404561
-
项目类别:
-
资助金额:$1.02万
-
财政年份:2016
-
负责人:Kai W Wucherpfennig
-
依托单位:
Cancer Immunology Training Grant
-
批准号:9315112
-
项目类别:
-
资助金额:$47.23万
-
财政年份:2016
-
负责人:Kai W Wucherpfennig
-
依托单位:
Transcriptional and epigenetic mechanisms of immunotherapy resistance in melanoma
-
批准号:10227095
-
项目类别:
-
资助金额:$36.76万
-
财政年份:2013
-
负责人:Kai W Wucherpfennig
-
依托单位:
Transcriptional and epigenetic mechanisms of immunotherapy resistance in melanoma
-
批准号:10658861
-
项目类别:
-
资助金额:$36.02万
-
财政年份:2013
-
负责人:Kai W Wucherpfennig
-
依托单位:
Transcriptional and epigenetic mechanisms of immunotherapy resistance in melanoma
-
批准号:10443722
-
项目类别:
-
资助金额:$36.02万
-
财政年份:2013
-
负责人:Kai W Wucherpfennig
-
依托单位:
MECHANISM OF PEPTIDE LOADING ONTO HUMAN MHC CLASS II MOLECULES
-
批准号:8361725
-
项目类别:
-
资助金额:$0.55万
-
财政年份:2011
-
负责人:Kai W Wucherpfennig
-
依托单位:
海外基金